LitCovid-sample-Enju  

PMC:7253482 / 5594-8420 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T837 0-2 TO denotes To
T838 3-11 VB denotes generate
T839 12-13 DT denotes a
T840 14-21 JJ denotes soluble
T841 22-27 NN denotes mimic
T842 28-30 IN denotes of
T843 31-34 DT denotes the
T844 35-40 JJ denotes viral
T845 41-42 NN denotes S
T846 43-51 NNS denotes proteins
T847 51-52 -COMMA- denotes ,
T848 53-55 PRP denotes we
T849 56-60 VBD denotes used
T850 61-64 DT denotes the
T851 65-78 JJ denotes 2P-stabilised
T852 79-90 JJ denotes native-like
T853 91-95 NNS denotes SARS
T854 96-99 CC denotes and
T855 100-104 NNS denotes MERS
T856 105-106 NN denotes S
T857 107-114 NN denotes protein
T858 115-123 NNS denotes antigens
T859 123-124 -COMMA- denotes ,
T860 125-128 DT denotes the
T861 129-135 NN denotes design
T862 136-139 CC denotes and
T863 140-150 NNS denotes structures
T864 151-153 IN denotes of
T865 154-159 WDT denotes which
T866 160-164 VBP denotes have
T867 165-169 VBN denotes been
T868 170-179 VBN denotes described
T869 180-190 RB denotes previously
T870 191-193 IN denotes by
T871 194-202 NNP denotes Pallesen
T872 203-205 NNP denotes et
T873 206-211 NN denotes al.41
T874 213-217 NNS denotes SARS
T875 217-218 -COMMA- denotes ,
T876 219-223 NNS denotes MERS
T877 224-227 CC denotes and
T878 228-232 NN denotes HKU1
T879 233-234 NN denotes S
T880 235-240 NNS denotes genes
T881 241-247 VBP denotes encode
T882 248-252 JJ denotes many
T883 253-261 JJ denotes N-linked
T884 262-268 NN denotes glycan
T885 269-276 NNS denotes sequons
T886 276-277 -SEMICOLON- denotes ;
T887 278-280 CD denotes 23
T888 280-281 -COMMA- denotes ,
T889 282-284 CD denotes 23
T890 285-288 CC denotes and
T891 289-291 CD denotes 29
T892 291-292 -COMMA- denotes ,
T893 293-305 RB denotes respectively
T894 306-307 -LRB- denotes (
T895 307-314 NN denotes Fig. 1a
T896 314-315 -RRB- denotes )
T897 317-319 PRP denotes We
T898 320-329 RB denotes initially
T899 330-336 VBD denotes sought
T900 337-339 TO denotes to
T901 340-354 RB denotes quantitatively
T902 355-361 VB denotes assess
T903 362-365 DT denotes the
T904 366-377 NN denotes composition
T905 378-380 IN denotes of
T906 381-384 DT denotes the
T907 385-397 NN denotes carbohydrate
T908 398-408 NNS denotes structures
T909 409-418 VBD denotes displayed
T910 419-421 IN denotes on
T911 422-425 DT denotes the
T912 426-427 NN denotes S
T913 428-441 NNS denotes glycoproteins
T914 443-451 VBN denotes N-linked
T915 452-459 NNS denotes glycans
T916 460-464 VBD denotes were
T917 465-478 RB denotes enzymatically
T918 479-487 VBN denotes released
T919 487-488 -COMMA- denotes ,
T920 489-502 RB denotes fluorescently
T921 503-511 VBN denotes labelled
T922 511-512 -COMMA- denotes ,
T923 513-516 CC denotes and
T924 517-526 VBN denotes subjected
T925 527-529 TO denotes to
T926 530-541 JJ denotes hydrophilic
T927 542-553 NN denotes interaction
T928 554-586 NN denotes chromatography-ultra-performance
T929 587-593 NN denotes liquid
T930 594-608 NN denotes chromatography
T931 609-610 -LRB- denotes (
T932 610-620 NN denotes HILIC-UPLC
T933 620-621 -RRB- denotes )
T934 623-632 NN denotes Treatment
T935 633-637 IN denotes with
T936 638-653 NN denotes endoglycosidase
T937 654-655 NN denotes H
T938 656-657 -LRB- denotes (
T939 657-661 NNP denotes Endo
T940 662-663 NN denotes H
T941 663-664 -RRB- denotes )
T942 665-673 VBD denotes revealed
T943 674-675 DT denotes a
T944 676-686 NN denotes population
T945 687-688 -LRB- denotes (
T946 688-692 NN denotes SARS
T947 693-697 CD denotes 32.2
T948 697-698 NN denotes %
T949 698-699 -SEMICOLON- denotes ;
T950 700-704 NNS denotes MERS
T951 705-709 CD denotes 33.8
T952 709-710 NN denotes %
T953 710-711 -COMMA- denotes ,
T954 712-716 NN denotes HKU1
T955 717-721 CD denotes 25.0
T956 721-722 NN denotes %
T957 722-723 -RRB- denotes )
T958 724-726 IN denotes of
T959 727-741 VBN denotes underprocessed
T960 742-759 JJ denotes oligomannose-type
T961 760-767 NNS denotes glycans
T962 768-769 -LRB- denotes (
T963 769-776 NN denotes Fig. 1b
T964 776-777 -RRB- denotes )
T965 779-783 DT denotes This
T966 784-795 NN denotes observation
T967 796-798 IN denotes of
T968 799-803 CC denotes both
T969 804-811 JJ denotes complex
T970 812-815 CC denotes and
T971 816-833 JJ denotes oligomannose-type
T972 834-841 NNS denotes glycans
T973 842-849 VBZ denotes reveals
T974 850-854 IN denotes that
T975 855-858 DT denotes the
T976 859-867 NN denotes majority
T977 868-870 IN denotes of
T978 871-879 JJ denotes N-linked
T979 880-887 NNS denotes glycans
T980 888-891 MD denotes can
T981 892-894 VB denotes be
T982 895-904 VBN denotes processed
T983 904-905 -COMMA- denotes ,
T984 906-914 IN denotes although
T985 915-920 EX denotes there
T986 921-923 VBZ denotes is
T987 924-931 JJ denotes limited
T988 932-942 NN denotes processing
T989 943-945 IN denotes at
T990 946-954 JJ denotes specific
T991 955-960 NNS denotes sites
T992 961-967 IN denotes across
T993 968-971 DT denotes the
T994 972-973 NN denotes S
T995 974-982 NNS denotes proteins
T996 984-986 PRP denotes It
T997 987-989 VBZ denotes is
T998 990-994 RB denotes also
T999 995-1006 JJ denotes interesting
T1000 1007-1009 TO denotes to
T1001 1010-1014 VB denotes note
T1002 1015-1019 IN denotes that
T1003 1020-1023 DT denotes the
T1004 1024-1036 NN denotes distribution
T1005 1037-1039 IN denotes of
T1006 1040-1057 JJ denotes oligomannose-type
T1007 1058-1065 NNS denotes glycans
T1008 1066-1069 VBD denotes was
T1009 1070-1075 JJ denotes broad
T1010 1075-1076 -COMMA- denotes ,
T1011 1077-1081 IN denotes with
T1012 1082-1093 NN denotes Man5GlcNAc2
T1013 1094-1096 TO denotes to
T1014 1097-1108 NN denotes Man9GlcNAc2
T1015 1109-1116 NNS denotes glycans
T1016 1117-1120 DT denotes all
T1017 1121-1128 VBP denotes present
T1018 1128-1129 -COMMA- denotes ,
T1019 1130-1137 IN denotes without
T1020 1138-1141 CD denotes one
T1021 1142-1152 JJ denotes particular
T1022 1153-1161 JJ denotes dominant
T1023 1162-1166 NN denotes peak
T1024 1166-1167 -COMMA- denotes ,
T1025 1168-1170 IN denotes as
T1026 1171-1173 VBZ denotes is
T1027 1174-1177 DT denotes the
T1028 1178-1182 NN denotes case
T1029 1183-1186 IN denotes for
T1030 1187-1191 DT denotes some
T1031 1192-1197 JJ denotes viral
T1032 1198-1211 NNS denotes glycoproteins
T1033 1211-1212 -COMMA- denotes ,
T1034 1213-1217 JJ denotes such
T1035 1218-1220 IN denotes as
T1036 1221-1226 NN denotes HIV-1
T1037 1227-1232 NN denotes Env36
T1038 1234-1237 DT denotes The
T1039 1238-1248 NN denotes proportion
T1040 1249-1251 IN denotes of
T1041 1252-1269 JJ denotes oligomannose-type
T1042 1270-1277 NNS denotes glycans
T1043 1278-1280 IN denotes on
T1044 1281-1292 JJ denotes recombinant
T1045 1293-1304 NN denotes coronavirus
T1046 1305-1306 NN denotes S
T1047 1307-1315 NNS denotes proteins
T1048 1316-1318 VBZ denotes is
T1049 1319-1329 JJ denotes consistent
T1050 1330-1334 IN denotes with
T1051 1335-1343 JJ denotes previous
T1052 1344-1351 NNS denotes studies
T1053 1352-1361 VBN denotes performed
T1054 1362-1364 IN denotes on
T1055 1365-1372 RB denotes virally
T1056 1373-1380 VBN denotes derived
T1057 1381-1385 NNS denotes MERS
T1058 1386-1389 CC denotes and
T1059 1390-1394 NN denotes SARS
T1060 1395-1406 NN denotes coronavirus
T1061 1407-1408 NN denotes S
T1062 1409-1422 NN denotes proteins17,42
T1063 1424-1437 NNS denotes Coronaviruses
T1064 1438-1442 VBP denotes have
T1065 1443-1447 VBN denotes been
T1066 1448-1458 RB denotes previously
T1067 1459-1463 VBN denotes been
T1068 1464-1472 VBN denotes reported
T1069 1473-1475 TO denotes to
T1070 1476-1480 VB denotes form
T1071 1481-1488 NNS denotes virions
T1072 1489-1491 IN denotes by
T1073 1492-1499 VBG denotes budding
T1074 1500-1504 IN denotes into
T1075 1505-1508 DT denotes the
T1076 1509-1514 NN denotes lumen
T1077 1515-1517 IN denotes of
T1078 1518-1529 JJ denotes endoplasmic
T1079 1530-1545 JJ denotes reticulum-Golgi
T1080 1546-1558 JJ denotes intermediate
T1081 1559-1571 NNS denotes compartments
T1082 1572-1573 -LRB- denotes (
T1083 1573-1578 NN denotes ERGIC
T1084 1578-1579 -RRB- denotes )
T1085 1579-1584 CD denotes 43,44
T1086 1586-1598 NNS denotes Observations
T1087 1599-1601 IN denotes of
T1088 1602-1609 NN denotes hybrid-
T1089 1610-1613 CC denotes and
T1090 1614-1626 JJ denotes complex-type
T1091 1627-1634 NNS denotes glycans
T1092 1635-1637 IN denotes on
T1093 1638-1645 RB denotes virally
T1094 1646-1653 VBN denotes derived
T1095 1654-1667 NN denotes material17,42
T1096 1668-1673 MD denotes would
T1097 1673-1674 -COMMA- denotes ,
T1098 1675-1682 RB denotes however
T1099 1682-1683 -COMMA- denotes ,
T1100 1684-1691 VBP denotes suggest
T1101 1692-1696 IN denotes that
T1102 1697-1699 PRP denotes it
T1103 1700-1702 VBZ denotes is
T1104 1703-1709 JJ denotes likely
T1105 1710-1714 IN denotes that
T1106 1715-1726 NN denotes coronavirus
T1107 1727-1734 NNS denotes virions
T1108 1735-1741 VBP denotes travel
T1109 1742-1749 IN denotes through
T1110 1750-1753 DT denotes the
T1111 1754-1759 NNP denotes Golgi
T1112 1760-1769 NN denotes apparatus
T1113 1770-1775 IN denotes after
T1114 1776-1782 NN denotes virion
T1115 1783-1792 NN denotes formation
T1116 1793-1795 IN denotes in
T1117 1796-1799 DT denotes the
T1118 1800-1805 NN denotes ERGIC
T1119 1806-1808 IN denotes en
T1120 1809-1814 NN denotes route
T1121 1815-1817 TO denotes to
T1122 1818-1821 DT denotes the
T1123 1822-1826 NN denotes cell
T1124 1827-1834 NN denotes surface
T1125 1834-1835 -COMMA- denotes ,
T1126 1836-1840 RB denotes thus
T1127 1841-1851 VBG denotes supporting
T1128 1852-1863 JJ denotes recombinant
T1129 1864-1874 NNS denotes immunogens
T1130 1875-1877 IN denotes as
T1131 1878-1884 NNS denotes models
T1132 1885-1887 IN denotes of
T1133 1888-1893 JJ denotes viral
T1134 1894-1907 NNS denotes glycoproteins
T1135 1909-1913 NNP denotes Fig.
T1136 1914-1915 CD denotes 1
T1137 1916-1929 JJ denotes Compositional
T1138 1930-1938 NN denotes analysis
T1139 1939-1941 IN denotes of
T1140 1942-1946 NNP denotes SARS
T1141 1946-1947 -COMMA- denotes ,
T1142 1948-1952 NNS denotes MERS
T1143 1953-1956 CC denotes and
T1144 1957-1961 NN denotes HKU1
T1145 1962-1969 NNS denotes glycans
T1146 1971-1972 DT denotes a
T1147 1973-1982 JJ denotes Schematic
T1148 1983-1997 NN denotes representation
T1149 1998-2000 IN denotes of
T1150 2001-2005 NNP denotes SARS
T1151 2005-2006 -COMMA- denotes ,
T1152 2007-2011 NNS denotes MERS
T1153 2012-2015 CC denotes and
T1154 2016-2020 NN denotes HKU1
T1155 2021-2032 NN denotes coronavirus
T1156 2033-2034 NN denotes S
T1157 2035-2048 NNS denotes glycoproteins
T1158 2048-2049 -COMMA- denotes ,
T1159 2050-2057 VBG denotes showing
T1160 2058-2061 DT denotes the
T1161 2062-2071 NNS denotes positions
T1162 2072-2074 IN denotes of
T1163 2075-2083 JJ denotes N-linked
T1164 2084-2097 NN denotes glycosylation
T1165 2098-2108 JJ denotes amino-acid
T1166 2109-2116 NNS denotes sequons
T1167 2117-2118 -LRB- denotes (
T1168 2118-2123 NN denotes NXS/T
T1169 2123-2124 -COMMA- denotes ,
T1170 2125-2130 WRB denotes where
T1171 2131-2136 NN denotes X ≠ P
T1172 2136-2137 -RRB- denotes )
T1173 2138-2143 VBN denotes shown
T1174 2144-2146 IN denotes as
T1175 2147-2155 NNS denotes branches
T1177 2697-2714 JJ denotes Oligomannose-type
T1178 2715-2722 NNS denotes glycans
T1179 2723-2726 VBP denotes are
T1180 2727-2740 RB denotes schematically
T1181 2741-2750 VBN denotes annotated
T1182 2751-2755 IN denotes with
T1183 2756-2763 NN denotes mannose
T1184 2764-2772 NNS denotes residues
T1185 2773-2775 IN denotes as
T1186 2776-2781 JJ denotes green
T1187 2782-2789 NNS denotes circles
T1188 2790-2793 CC denotes and
T1189 2794-2800 NN denotes GlcNAc
T1190 2801-2809 NNS denotes residues
T1191 2810-2812 IN denotes as
T1192 2813-2817 JJ denotes blue
T1193 2818-2825 NNS denotes squares
R1000 T995 T994 arg1Of proteins,S
R1001 T1001 T996 arg1Of note,It
R1002 T1001 T997 arg1Of note,is
R1003 T999 T997 arg2Of interesting,is
R1004 T997 T998 arg1Of is,also
R1005 T1001 T999 arg1Of note,interesting
R1006 T1001 T1000 arg1Of note,to
R1007 T1008 T1001 arg2Of was,note
R1008 T1008 T1002 arg1Of was,that
R1009 T1004 T1003 arg1Of distribution,the
R1010 T1004 T1005 arg1Of distribution,of
R1011 T1007 T1005 arg2Of glycans,of
R1012 T1007 T1006 arg1Of glycans,oligomannose-type
R1013 T1004 T1008 arg1Of distribution,was
R1014 T1009 T1008 arg2Of broad,was
R1015 T1004 T1009 arg1Of distribution,broad
R1016 T1017 T1009 arg2Of present,broad
R1017 T1009 T1010 arg1Of broad,","
R1018 T1009 T1011 arg1Of broad,with
R1019 T1012 T1011 arg2Of Man5GlcNAc2,with
R1020 T1014 T1013 arg1Of Man9GlcNAc2,to
R1021 T1015 T1014 arg2Of glycans,Man9GlcNAc2
R1022 T1017 T1016 arg1Of present,all
R1023 T1014 T1017 arg1Of Man9GlcNAc2,present
R1024 T1017 T1018 arg1Of present,","
R1025 T1017 T1019 arg1Of present,without
R1026 T1023 T1019 arg2Of peak,without
R1027 T1023 T1020 arg1Of peak,one
R1028 T1023 T1021 arg1Of peak,particular
R1029 T1023 T1022 arg1Of peak,dominant
R1030 T1017 T1024 arg1Of present,","
R1031 T1017 T1025 arg1Of present,as
R1032 T1026 T1025 arg2Of is,as
R1033 T1028 T1026 arg1Of case,is
R1034 T1028 T1027 arg1Of case,the
R1035 T1028 T1029 arg1Of case,for
R1036 T1032 T1029 arg2Of glycoproteins,for
R1037 T1032 T1030 arg1Of glycoproteins,some
R1038 T1032 T1031 arg1Of glycoproteins,viral
R1039 T1032 T1033 arg1Of glycoproteins,","
R1040 T1035 T1034 arg1Of as,such
R1041 T1032 T1035 arg1Of glycoproteins,as
R1042 T1037 T1035 arg2Of Env36,as
R1043 T1037 T1036 arg1Of Env36,HIV-1
R1044 T1039 T1038 arg1Of proportion,The
R1045 T1039 T1040 arg1Of proportion,of
R1046 T1042 T1040 arg2Of glycans,of
R1047 T1042 T1041 arg1Of glycans,oligomannose-type
R1048 T1039 T1043 arg1Of proportion,on
R1049 T1047 T1043 arg2Of proteins,on
R1050 T1047 T1044 arg1Of proteins,recombinant
R1051 T1047 T1045 arg1Of proteins,coronavirus
R1052 T1047 T1046 arg1Of proteins,S
R1053 T1039 T1048 arg1Of proportion,is
R1054 T1049 T1048 arg2Of consistent,is
R1055 T1039 T1049 arg1Of proportion,consistent
R1056 T1049 T1050 arg1Of consistent,with
R1057 T1052 T1050 arg2Of studies,with
R1058 T1052 T1051 arg1Of studies,previous
R1059 T1052 T1053 arg2Of studies,performed
R1060 T1053 T1054 arg1Of performed,on
R1061 T1058 T1054 arg2Of and,on
R1062 T1056 T1055 arg1Of derived,virally
R1063 T1057 T1056 arg1Of MERS,derived
R1064 T1057 T1058 arg1Of MERS,and
R1065 T1062 T1058 arg2Of "proteins17,42",and
R1066 T1062 T1059 arg1Of "proteins17,42",SARS
R1067 T1062 T1060 arg1Of "proteins17,42",coronavirus
R1068 T1062 T1061 arg1Of "proteins17,42",S
R1069 T1063 T1064 arg1Of Coronaviruses,have
R1070 T1068 T1064 arg2Of reported,have
R1071 T1063 T1065 arg1Of Coronaviruses,been
R1072 T1068 T1065 arg2Of reported,been
R1073 T1068 T1066 arg1Of reported,previously
R1074 T1063 T1067 arg1Of Coronaviruses,been
R1075 T1068 T1067 arg2Of reported,been
R1076 T1063 T1068 arg2Of Coronaviruses,reported
R1077 T1070 T1068 arg3Of form,reported
R1078 T1070 T1069 arg1Of form,to
R1079 T1063 T1070 arg1Of Coronaviruses,form
R1080 T1071 T1070 arg2Of virions,form
R1081 T1070 T1072 arg1Of form,by
R1082 T1073 T1072 arg2Of budding,by
R1083 T1063 T1073 arg1Of Coronaviruses,budding
R1084 T1073 T1074 arg1Of budding,into
R1085 T1076 T1074 arg2Of lumen,into
R1086 T1076 T1075 arg1Of lumen,the
R1087 T1076 T1077 arg1Of lumen,of
R1088 T1081 T1077 arg2Of compartments,of
R1089 T1081 T1078 arg1Of compartments,endoplasmic
R1090 T1081 T1079 arg1Of compartments,reticulum-Golgi
R1091 T1081 T1080 arg1Of compartments,intermediate
R1092 T1081 T1082 arg1Of compartments,(
R1093 T1083 T1082 arg2Of ERGIC,(
R1094 T1084 T1082 arg3Of ),(
R1095 T1081 T1085 arg1Of compartments,"43,44"
R1096 T1086 T1087 arg1Of Observations,of
R1097 T1089 T1087 arg2Of and,of
R1098 T1088 T1089 arg1Of hybrid-,and
R1099 T1091 T1089 arg2Of glycans,and
R1100 T1091 T1090 arg1Of glycans,complex-type
R1101 T1089 T1092 arg1Of and,on
R1102 T1095 T1092 arg2Of "material17,42",on
R1103 T1094 T1093 arg1Of derived,virally
R1104 T1095 T1094 arg1Of "material17,42",derived
R1105 T1086 T1096 arg1Of Observations,would
R1106 T1100 T1099 arg2Of suggest,","
R1107 T1086 T1100 arg1Of Observations,suggest
R1108 T1103 T1100 arg2Of is,suggest
R1109 T1103 T1101 arg1Of is,that
R1110 T1102 T1103 arg1Of it,is
R1111 T1104 T1103 arg2Of likely,is
R1112 T1102 T1104 arg1Of it,likely
R1113 T1108 T1104 arg2Of travel,likely
R1114 T1108 T1105 arg1Of travel,that
R1115 T1107 T1106 arg1Of virions,coronavirus
R1116 T1107 T1108 arg1Of virions,travel
R1117 T1108 T1109 arg1Of travel,through
R1118 T1112 T1109 arg2Of apparatus,through
R1119 T1112 T1110 arg1Of apparatus,the
R1120 T1112 T1111 arg1Of apparatus,Golgi
R1121 T1112 T1113 arg1Of apparatus,after
R1122 T1115 T1113 arg2Of formation,after
R1123 T1115 T1114 arg1Of formation,virion
R1124 T1115 T1116 arg1Of formation,in
R1125 T1118 T1116 arg2Of ERGIC,in
R1126 T1118 T1117 arg1Of ERGIC,the
R1127 T1118 T1119 arg1Of ERGIC,en
R1128 T1120 T1119 arg2Of route,en
R1129 T1118 T1121 arg1Of ERGIC,to
R1130 T1124 T1121 arg2Of surface,to
R1131 T1124 T1122 arg1Of surface,the
R1132 T1124 T1123 arg1Of surface,cell
R1133 T1103 T1125 arg1Of is,","
R1134 T1127 T1126 arg1Of supporting,thus
R1135 T1102 T1127 arg1Of it,supporting
R1136 T1129 T1127 arg2Of immunogens,supporting
R1137 T1103 T1127 modOf is,supporting
R1138 T1129 T1128 arg1Of immunogens,recombinant
R1139 T1127 T1130 arg1Of supporting,as
R1140 T1131 T1130 arg2Of models,as
R1141 T1131 T1132 arg1Of models,of
R1142 T1134 T1132 arg2Of glycoproteins,of
R1143 T1134 T1133 arg1Of glycoproteins,viral
R1144 T1138 T1135 arg1Of analysis,Fig.
R1145 T1135 T1136 arg1Of Fig.,1
R1146 T1138 T1137 arg1Of analysis,Compositional
R1147 T1138 T1139 arg1Of analysis,of
R1148 T1140 T1139 arg2Of SARS,of
R1149 T1140 T1141 arg1Of SARS,","
R1150 T1143 T1141 arg2Of and,","
R1151 T1142 T1143 arg1Of MERS,and
R1152 T1145 T1143 arg2Of glycans,and
R1153 T1145 T1144 arg1Of glycans,HKU1
R1154 T1148 T1146 arg1Of representation,a
R1155 T1148 T1147 arg1Of representation,Schematic
R1156 T1148 T1149 arg1Of representation,of
R1157 T1153 T1149 arg2Of and,of
R1158 T1150 T1151 arg1Of SARS,","
R1159 T1152 T1151 arg2Of MERS,","
R1160 T1151 T1153 arg1Of ",",and
R1161 T1157 T1153 arg2Of glycoproteins,and
R1162 T1157 T1154 arg1Of glycoproteins,HKU1
R1163 T1157 T1155 arg1Of glycoproteins,coronavirus
R1164 T1157 T1156 arg1Of glycoproteins,S
R1165 T1148 T1158 arg1Of representation,","
R1166 T1148 T1159 arg1Of representation,showing
R1167 T1161 T1159 arg2Of positions,showing
R1168 T1161 T1160 arg1Of positions,the
R1169 T1161 T1162 arg1Of positions,of
R1170 T1166 T1162 arg2Of sequons,of
R1171 T1166 T1163 arg1Of sequons,N-linked
R1172 T1166 T1164 arg1Of sequons,glycosylation
R1173 T1166 T1165 arg1Of sequons,amino-acid
R1174 T1166 T1167 arg1Of sequons,(
R1175 T1168 T1167 arg2Of NXS/T,(
R1176 T1172 T1167 arg3Of ),(
R1177 T1168 T1169 arg1Of NXS/T,","
R1178 T1171 T1170 arg1Of X ≠ P,where
R1179 T1168 T1171 arg1Of NXS/T,X ≠ P
R1180 T1166 T1173 arg2Of sequons,shown
R1181 T1173 T1174 arg1Of shown,as
R1182 T1175 T1174 arg2Of branches,as
R1183 T1178 T1177 arg1Of glycans,Oligomannose-type
R1184 T1178 T1179 arg1Of glycans,are
R1185 T1181 T1179 arg2Of annotated,are
R1186 T1181 T1180 arg1Of annotated,schematically
R1187 T1178 T1181 arg2Of glycans,annotated
R1188 T1181 T1182 arg1Of annotated,with
R1189 T1184 T1182 arg2Of residues,with
R1190 T1184 T1183 arg1Of residues,mannose
R1191 T1181 T1185 arg1Of annotated,as
R1192 T1188 T1185 arg2Of and,as
R1193 T1187 T1186 arg1Of circles,green
R1194 T1187 T1188 arg1Of circles,and
R1195 T1190 T1188 arg2Of residues,and
R1196 T1190 T1189 arg1Of residues,GlcNAc
R1197 T1181 T1191 arg1Of annotated,as
R1198 T1193 T1191 arg2Of squares,as
R1199 T1193 T1192 arg1Of squares,blue
R838 T838 T837 arg1Of generate,To
R839 T849 T837 modOf used,To
R840 T848 T838 arg1Of we,generate
R841 T841 T838 arg2Of mimic,generate
R842 T841 T839 arg1Of mimic,a
R843 T841 T840 arg1Of mimic,soluble
R844 T841 T842 arg1Of mimic,of
R845 T846 T842 arg2Of proteins,of
R846 T846 T843 arg1Of proteins,the
R847 T846 T844 arg1Of proteins,viral
R848 T846 T845 arg1Of proteins,S
R849 T849 T847 arg1Of used,","
R850 T848 T849 arg1Of we,used
R851 T854 T849 arg2Of and,used
R852 T853 T850 arg1Of SARS,the
R853 T853 T851 arg1Of SARS,2P-stabilised
R854 T853 T852 arg1Of SARS,native-like
R855 T853 T854 arg1Of SARS,and
R856 T858 T854 arg2Of antigens,and
R857 T858 T855 arg1Of antigens,MERS
R858 T858 T856 arg1Of antigens,S
R859 T858 T857 arg1Of antigens,protein
R860 T868 T859 arg1Of described,","
R861 T862 T860 arg1Of and,the
R862 T861 T862 arg1Of design,and
R863 T863 T862 arg2Of structures,and
R864 T862 T864 arg1Of and,of
R865 T858 T864 arg2Of antigens,of
R866 T858 T865 arg1Of antigens,which
R867 T862 T866 arg1Of and,have
R868 T868 T866 arg2Of described,have
R869 T862 T867 arg1Of and,been
R870 T868 T867 arg2Of described,been
R871 T873 T868 arg1Of al.41,described
R872 T862 T868 arg2Of and,described
R873 T868 T869 arg1Of described,previously
R874 T873 T870 arg2Of al.41,by
R875 T872 T871 arg1Of et,Pallesen
R876 T873 T872 arg1Of al.41,et
R877 T874 T875 arg1Of SARS,","
R878 T876 T875 arg2Of MERS,","
R879 T875 T877 arg1Of ",",and
R880 T880 T877 arg2Of genes,and
R881 T880 T878 arg1Of genes,HKU1
R882 T880 T879 arg1Of genes,S
R883 T877 T881 arg1Of and,encode
R884 T886 T881 arg2Of ;,encode
R885 T885 T882 arg1Of sequons,many
R886 T885 T883 arg1Of sequons,N-linked
R887 T885 T884 arg1Of sequons,glycan
R888 T885 T886 arg1Of sequons,;
R889 T890 T886 arg2Of and,;
R890 T887 T888 arg1Of 23,","
R891 T889 T888 arg2Of 23,","
R892 T888 T890 arg1Of ",",and
R893 T891 T890 arg2Of 29,and
R894 T886 T892 arg1Of ;,","
R895 T886 T893 arg1Of ;,respectively
R896 T886 T894 arg1Of ;,(
R897 T895 T894 arg2Of Fig. 1a,(
R898 T896 T894 arg3Of ),(
R899 T899 T898 arg1Of sought,initially
R900 T897 T899 arg1Of We,sought
R901 T902 T899 arg2Of assess,sought
R902 T902 T900 arg1Of assess,to
R903 T902 T901 arg1Of assess,quantitatively
R904 T897 T902 arg1Of We,assess
R905 T904 T902 arg2Of composition,assess
R906 T904 T903 arg1Of composition,the
R907 T904 T905 arg1Of composition,of
R908 T907 T905 arg2Of carbohydrate,of
R909 T907 T906 arg1Of carbohydrate,the
R910 T908 T909 arg1Of structures,displayed
R911 T904 T909 arg2Of composition,displayed
R912 T909 T910 arg1Of displayed,on
R913 T913 T910 arg2Of glycoproteins,on
R914 T913 T911 arg1Of glycoproteins,the
R915 T913 T912 arg1Of glycoproteins,S
R916 T915 T914 arg2Of glycans,N-linked
R917 T915 T916 arg1Of glycans,were
R918 T919 T916 arg2Of ",",were
R919 T919 T917 arg1Of ",",enzymatically
R920 T915 T918 arg2Of glycans,released
R921 T918 T919 arg1Of released,","
R922 T923 T919 arg2Of and,","
R923 T923 T920 arg1Of and,fluorescently
R924 T915 T921 arg2Of glycans,labelled
R925 T923 T922 arg1Of and,","
R926 T921 T923 arg1Of labelled,and
R927 T924 T923 arg2Of subjected,and
R928 T915 T924 arg2Of glycans,subjected
R929 T924 T925 arg1Of subjected,to
R930 T930 T925 arg2Of chromatography,to
R931 T930 T926 arg1Of chromatography,hydrophilic
R932 T930 T927 arg1Of chromatography,interaction
R933 T930 T928 arg1Of chromatography,chromatography-ultra-performance
R934 T930 T929 arg1Of chromatography,liquid
R935 T930 T931 arg1Of chromatography,(
R936 T932 T931 arg2Of HILIC-UPLC,(
R937 T933 T931 arg3Of ),(
R938 T934 T935 arg1Of Treatment,with
R939 T937 T935 arg2Of H,with
R940 T937 T936 arg1Of H,endoglycosidase
R941 T937 T938 arg1Of H,(
R942 T940 T938 arg2Of H,(
R943 T941 T938 arg3Of ),(
R944 T940 T939 arg1Of H,Endo
R945 T934 T942 arg1Of Treatment,revealed
R946 T944 T942 arg2Of population,revealed
R947 T944 T943 arg1Of population,a
R948 T944 T945 arg1Of population,(
R949 T948 T945 arg2Of %,(
R950 T957 T945 arg3Of ),(
R951 T948 T946 arg1Of %,SARS
R952 T948 T947 arg1Of %,32.2
R953 T948 T949 arg1Of %,;
R954 T952 T949 arg2Of %,;
R955 T952 T950 arg1Of %,MERS
R956 T952 T951 arg1Of %,33.8
R957 T948 T953 arg1Of %,","
R958 T956 T953 arg2Of %,","
R959 T956 T954 arg1Of %,HKU1
R960 T956 T955 arg1Of %,25.0
R961 T944 T958 arg1Of population,of
R962 T961 T958 arg2Of glycans,of
R963 T961 T959 arg2Of glycans,underprocessed
R964 T961 T960 arg1Of glycans,oligomannose-type
R965 T961 T962 arg1Of glycans,(
R966 T963 T962 arg2Of Fig. 1b,(
R967 T964 T962 arg3Of ),(
R968 T966 T965 arg1Of observation,This
R969 T966 T967 arg1Of observation,of
R970 T972 T967 arg2Of glycans,of
R971 T972 T968 arg1Of glycans,both
R972 T972 T969 arg1Of glycans,complex
R973 T969 T970 arg1Of complex,and
R974 T971 T970 arg2Of oligomannose-type,and
R975 T972 T971 arg1Of glycans,oligomannose-type
R976 T966 T973 arg1Of observation,reveals
R977 T982 T973 arg2Of processed,reveals
R978 T982 T974 arg1Of processed,that
R979 T976 T975 arg1Of majority,the
R980 T976 T977 arg1Of majority,of
R981 T979 T977 arg2Of glycans,of
R982 T979 T978 arg1Of glycans,N-linked
R983 T976 T980 arg1Of majority,can
R984 T982 T980 arg2Of processed,can
R985 T976 T981 arg1Of majority,be
R986 T982 T981 arg2Of processed,be
R987 T976 T982 arg2Of majority,processed
R988 T982 T983 arg1Of processed,","
R989 T982 T984 arg1Of processed,although
R990 T986 T984 arg2Of is,although
R991 T985 T986 arg1Of there,is
R992 T988 T986 arg2Of processing,is
R993 T988 T987 arg1Of processing,limited
R994 T988 T989 arg1Of processing,at
R995 T991 T989 arg2Of sites,at
R996 T991 T990 arg1Of sites,specific
R997 T991 T992 arg1Of sites,across
R998 T995 T992 arg2Of proteins,across
R999 T995 T993 arg1Of proteins,the